TREACE MEDICAL CONCEPTS INC (TMCI) Stock Analyst Ratings
USA - NASDAQ:TMCI - US89455T1097 - Common Stock
6.39 USD
+0.04 (+0.63%)
6.39 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 77% to TMCI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.67. This target is 35.68% above the current price.
TMCI was analyzed by 12 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about TMCI.
In the previous month the buy percentage consensus was at a similar level.
TMCI was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-09-04 | Truist Securities | Maintains | Hold -> Hold |
| 2025-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-08 | Stifel | Maintains | Hold -> Hold |
| 2025-05-09 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-13 | Truist Securities | Maintains | Hold -> Hold |
| 2025-03-03 | Truist Securities | Maintains | Hold -> Hold |
| 2024-12-31 | Lake Street | Initiate | Buy |
| 2024-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2024-11-06 | Stifel | Maintains | Hold -> Hold |
| 2024-10-14 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-07 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-16 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-16 | UBS | Downgrade | Buy -> Neutral |
| 2024-05-08 | BTIG | Downgrade | Buy -> Neutral |
| 2024-05-08 | UBS | Maintains | Buy -> Buy |
| 2024-05-08 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-08 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-05-08 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2024-05-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-12-22 | Truist Securities | Maintains | Buy -> Buy |
| 2023-11-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-10 | Stifel | Maintains | Buy -> Buy |
| 2023-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2023-10-02 | Stifel | Reiterate | Buy -> Buy |
| 2023-09-29 | UBS | Initiate | Buy |
| 2023-09-12 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
TREACE MEDICAL CONCEPTS INC / TMCI FAQ
What do analysts expect the price target to be for TREACE MEDICAL CONCEPTS INC (TMCI)?
12 analysts have analysed TMCI and the average price target is 8.67 USD. This implies a price increase of 35.68% is expected in the next year compared to the current price of 6.39.
How do analysts rate TREACE MEDICAL CONCEPTS INC (TMCI)?
The consensus rating for TREACE MEDICAL CONCEPTS INC (TMCI) is 76.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for TMCI stock?
The number of analysts covering TREACE MEDICAL CONCEPTS INC (TMCI) is 12.